Malignant glioma sensitivity to radiotherapy, high-dose tamoxifen, and hypericin: Corroborating clinical response in vitro: Case report

Neurosurgery

Volumn 38, Issue 3, 1996, Pages 587-591

  Zhang, Wei ^a   Hinton, David R ^a   Surnock, Amy A ^a   Couldwell, William T ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Trinity Health Minot   (United States)

Author keywords

Chemotherapy; Glioma; Hypericin; Protein kinase C; Radiation therapy; Tamoxifen

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; HYPERICIN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR; TAMOXIFEN;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; DRUG SENSITIVITY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOSENSITIVITY; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BRAIN NEOPLASMS; CELL DIVISION; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; CRANIOTOMY; DOMINANCE, CEREBRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PERYLENE; RADIOTHERAPY, ADJUVANT; REOPERATION; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0030025152     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199603000-00035     Document Type: Article

References (17)

1. Baltuch G, Couldwell WT, Villemure JG, Yong VW: Protein kinase C inhibitors suppress cell growth in established and low passage glioma cell lines: A comparison between staurosporine and tamoxifen. Neurosurgery 33:495-501, 1993.
2. Baltuch G, Shenouda G, Langleben A, Villemure JG: High dose tamoxifen in the treatment of recurrent high grade glioma: A report of clinical stabilization and tumor regression. Can J Neurol Sci 20:168-170, 1993.
3. Carmicheal J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of radiosensitivity. Cancer Res 47:943-946, 1987.
4. Couldwell WT, Antel JP, Apuzzo MLJ, Yong VW: Inhibition of growth of established human glioma lines by modulators of the protein kinase C second messenger system. J Neurosurg 73:594-600, 1990.
5. Couldwell WT, Antel JP, Yong VW: Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas: Part II - Effects of glioma mitogens and modulators of PKC. Neurosurgery 31:717-724, 1992.
6. Couldwell WT, Gopalakrishna R, Hinton DR, He S, Weiss MH, Apuzzo MLJ, Law RE: Hypericin: A potential antiglioma therapy. Neurosurgery 35:705-710, 1994.
7. Couldwell WT, Weiss MH, DeGiorgio CM, Weiner LP, Hinton DR, Ehresmann GR, Conti PS, Apuzzo MLJ: Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery 32:485-490, 1993.
8. Levin VL, Sheline GE, Gutin PH: Neoplasms of the central nervous system, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer Principles and Practice of Oncology. Philadelphia, J.B. Lippincott, 1989, ed 3, vol 2, pp 1557-1611.
9. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB: Inhibition of protein kinase C by tamoxifen. Cancer Res 45:1462-1465, 1985.
10. Pasqualmi JR, Sumida C, Giambiagi N: Pharmacodynamic and biological effects of anti-estrogen in different models. J Steroid Biochem 31:613-643, 1988.
11. Pollack IF, Randall MS, Solomon DH, Kristofik MP, Kelly RH, Selker RG, Vertosik FT: Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro. Cancer Res 50:7134-7138, 1990.
12. Ramsay J, Ward R, Bleehen NM: Radiosensitivity testing of human malignant gliomas. Int J Radiat Oncol Biol Phys 24:675-680, 1992.
13. Vertosik FT, Selker RG, Pollack IF, Arena V: The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: Preliminary results in a series of "failed" patients. Neurosurgery 30:897-903, 1992.
14. Walker MD, Alexander E, Hunt WE, MacCarty CS, Mahaley MS, Mealey J: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: A cooperative clinical trial. J Neurosurg 49-333-343, 1978.
15. Zhang W, Hara A, Sakai N, Andoh T, Yamada H, Nozawa Y: Radiosensitization and inhibition of deoxyribonucleic acid repair in rat glioma cells by long-term treatment with 12-O-tetradecanoylphorbol 13-acetate. Neurosurgery 32:432-437, 1993.
16. Zhang W, Yamada H, Sakai N, Niikawa S, Nozawa Y: Enhancement of radiosensitivity by tamoxifen in C6 glioma cells. Neurosurgery 31: 725-730, 1992.
17. Zhang W, Yamada H, Sakai N, Nozawa Y: Sensitization of C6 glioma cells to radiation by staurosporine, a potent protein kinase C inhibitor. J Neurooncol 15:1-7, 1993.